Sponsor content

Pushing the boundaries of regenerative medicine

Plasticell is leveraging its innovative combinatorial screening technology for a broad range of cell and gene therapy applications, whereas spin-out Progenitor Therapeutics focuses on small-molecule regenerative drug discovery.

Go to the profile of Plasticell
Sep 06, 2016
1
0
Page of
Go to the profile of Plasticell

Plasticell

Plasticell is a biotechnology company that is developing therapies derived from research using its award-winning proprietary high throughput combinatorial cell culture technology named CombiCult®.

No comments yet.